Fundraising Fox
Ali Behbahani
InvestorPartner, co-head of healthcare team at New Enterprise Associates (NEA)
Menlo Park, CA
Writes $2M – $50M checks · typically $25M
Find your path to Ali
Sign up to see every warm intro you have to Ali
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ali. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Ali Behbahani is a Partner at NEA, which he joined in 2007, and co-heads the firm's healthcare team with a focus on biopharmaceuticals and medical devices. He previously worked at The Medicines Company, Morgan Stanley, and Lehman Brothers, and conducted research at the National Institutes of Health and Duke University. He holds an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and undergraduate degrees in biomedical engineering, electrical engineering, and chemistry from Duke University.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthMedical Devices
Beyond investing
- Education
- Studied at University of Pennsylvania School of Medicine (M.D.) Studied at University of Pennsylvania Wharton School (MBA) Studied at Duke University (bachelor's degrees, biomedical engineering, electrical engineering and chemistry)
- Awards
- He graduated with honors from the Wharton School and was a Palmer Scholar. He graduated summa cum laude from Duke University and received his bachelor's degrees with distinction.
From published sources — common ground for a warm intro.
Deals · 18
Nexo Therapeutics, Inc.Board seat
via New Enterprise Associates (NEA) · filed Mar 2026 · $60M raise
Spyglass PharmaBoard seat
via New Enterprise Associates (NEA) · filed Jun 2025 · $75M raise
Tune TherapeuticsBoard seat
via New Enterprise Associates (NEA) · filed Jan 2025 · $208M raise
858 Therapeutics, Inc.Board seat
via New Enterprise Associates (NEA) · filed Jul 2024 · $50.4M raise
Launchpad Therapeutics, Inc.Board seat
via New Enterprise Associates (NEA) · filed Dec 2022 · $30M raise
FirstLight Bio, Inc.Board seat
via New Enterprise Associates (NEA) · filed Apr 2022 · $25.4M raise
Monte Rosa TherapeuticsBoard seat
via New Enterprise Associates (NEA) · filed Sep 2020 · $96M raise
Genocea BiosciencesBoard seat
via New Enterprise Associates (NEA) · filed Aug 2020 · $79.9M raise
ArcellxBoard seat
via New Enterprise Associates (NEA) · filed Oct 2019 · $83.7M raise
Nkarta, Inc.Board seat
via New Enterprise Associates (NEA) · filed Sep 2019 · $114.6M raise
Aset TherapeuticsBoard seat
via New Enterprise Associates (NEA) · filed Jul 2019 · $87.2M raise
CVRxBoard seat
via New Enterprise Associates (NEA) · filed May 2019 · $93M raise
Minerva SurgicalBoard seat
via New Enterprise Associates (NEA) · filed Mar 2018 · $20M raise
Oyster Point Pharma, Inc.Board seat
via New Enterprise Associates (NEA) · filed Oct 2017 · $43.1M raise
Ivantis IncBoard seat
via New Enterprise Associates (NEA) · filed Jan 2017 · $25M raise
Solace TherapeuticsBoard seat
via New Enterprise Associates (NEA) · filed Sep 2016 · $20M raise
Rotation MedicalBoard seat
via New Enterprise Associates (NEA) · filed Aug 2016 · $8M raise
CardionomicBoard seat
via New Enterprise Associates (NEA) · filed Oct 2015 · $21.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AdaptimmuneCRISPR TherapeuticsNkarta
Investor
AbcuroAcclarentAdaptimmuneAmber TherapeuticsBlack Diamond TherapeuticsCHARM TherapeuticsClarVista MedicalCRISPREnceladus BioEscient PharmaceuticalsInterMuneKorro BioOculeveRa PharmaceuticalsRed Ridge BioSpyglass OphthalmicsStablixTidal Therapeutics
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at New Enterprise Associates (NEA)
Network15
▶3 more connections
Investors connected to Ali in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ali Behbahani?
- Ali Behbahani is a Partner at NEA, which he joined in 2007, and co-heads the firm's healthcare team with a focus on biopharmaceuticals and medical devices. He previously worked at The Medicines Company, Morgan Stanley, and Lehman Brothers, and conducted research at the National Institutes of Health and Duke University. He holds an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and undergraduate degrees in biomedical engineering, electrical engineering, and chemistry from Duke University.
- Where does Ali Behbahani work?
- Ali Behbahani is Partner, co-head of healthcare team at New Enterprise Associates (NEA).
- What does Ali Behbahani invest in?
- Ali Behbahani invests in Biotech, Digital Health, Medical Devices.
- What check size does Ali Behbahani write?
- Ali Behbahani typically writes checks of $2M – $50M.
- What boards does Ali Behbahani sit on?
- Ali Behbahani holds tracked board seats at 858 Therapeutics, Inc., Arcellx, Arcellx, Aset Therapeutics, Cardionomic, Cardionomic, CRISPR, CVRx, CVRx, FirstLight Bio, Inc..
- What companies has Ali Behbahani invested in?
- Investments tracked here include Adaptimmune, Arcellx, CRISPR Therapeutics, Nkarta, 858 Therapeutics, Inc., Abcuro, Acclarent, Adaptimmune, Amber Therapeutics, Black Diamond Therapeutics, CHARM Therapeutics, ClarVista Medical, and 19 more.
- What awards has Ali Behbahani received?
- He graduated with honors from the Wharton School and was a Palmer Scholar. He graduated summa cum laude from Duke University and received his bachelor's degrees with distinction.
- Does Ali Behbahani lead rounds?
- Yes — Ali Behbahani has led 4 tracked investments.
About this profile. Compiled from public sources — New Enterprise Associates (NEA)'s own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights